# Wood Blewit (Lepista nuda (Bull.) Cooke)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/wood-blewit-lepista-nuda-bull-cooke
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 1 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Lepista nuda (Bull.) Cooke, Wood Blewit, Pied Bleu, Blue Leg Mushroom, Tricholoma nudum, Clitocybe nuda

## Overview

Lepista nuda contains p-hydroxybenzoic acid (587.90 µg/g dw), catechin (400.20 µg/g dw), ellagic acid, chlorogenic acid, and linolelaidic acid, which collectively drive [free radical scaveng](/ingredients/condition/antioxidant)ing and reducing power activities. Methanolic extracts demonstrate measurable antioxidant potency with DPPH EC₅₀ values of 0.98–1.18 mg/mL and β-carotene bleaching EC₅₀ of 0.22–0.39 mg/mL, outperforming some synthetic standards in the latter assay.

## Health Benefits

- **[Antioxidant Activity](/ingredients/condition/antioxidant)**: Methanolic extracts scavenge free radicals via phenolic compounds including p-hydroxybenzoic acid, catechin, and ellagic acid, achieving DPPH EC₅₀ values of 0.98–1.18 mg/mL, indicating concentration-dependent radical neutralization.
- **Lipid Peroxidation Inhibition**: The β-carotene bleaching assay demonstrates strong inhibition of lipid oxidation with EC₅₀ of 0.22–0.39 mg/mL, attributable to phenolics and the polyunsaturated fatty acid linolelaidic acid (21.13% of GC-MS-detected biomolecules).
- **Reducing Power**: Ferric-reducing power assays yield EC₅₀ of 0.48–0.63 mg/mL, reflecting the electron-donating capacity of gallic acid (131.7 µg/g dw), protocatechuic acid, and chlorogenic acid present in the fruiting body.
- **Flavonoid-Associated Benefits**: Total flavonoid content of 19.02 ± 0.80 mg catechin equivalents/g dme contributes to the broader polyphenol profile, with flavonoids generally associated with [anti-inflammatory](/ingredients/condition/inflammation) and vascular protective effects, though these have not been confirmed specifically for L. nuda.
- **Nutritional Amino Acid Contribution**: GC-MS analysis identifies leucine as the dominant amino acid at 9.05% of detected biomolecules, supporting dietary protein quality and branched-chain amino acid intake when consumed as a food.
- **Potential Ergothioneine Content**: Related Basidiomycete literature documents ergothioneine (EGT) in comparable species; L. nuda mycelium studies suggest possible EGT presence, a unique thiol antioxidant with [mitochondrial](/ingredients/condition/energy) protective properties, though quantification in L. nuda specifically remains unconfirmed.
- **Broad Phytochemical Spectrum**: The 66 GC-MS-identified biomolecules encompassing sugars, organic acids, and fatty acids alongside 13 HPLC-MS-confirmed phenolics reflect a chemically diverse profile that may provide synergistic nutritional and antioxidant effects beyond any single compound.

## Mechanism of Action

The primary antioxidant mechanism of Lepista nuda extracts involves hydrogen atom transfer and single electron transfer from polyphenolic compounds—principally p-hydroxybenzoic acid, catechin, ellagic acid, and chlorogenic acid—to [reactive oxygen species](/ingredients/condition/antioxidant), quenching radicals before they damage cellular lipids, proteins, and DNA. Gallic acid and protocatechuic acid, both hydroxybenzoic acid derivatives, further contribute through metal chelation, reducing the availability of transition metal ions (Fe²⁺, Cu²⁺) that catalyze Fenton-type reactions. Linolelaidic acid, the dominant fatty acid at 21.13% of GC-MS biomolecules, may participate in membrane-level modulation of oxidative stress, though its precise mechanistic role in the extract's activity has not been isolated experimentally. No specific receptor binding, enzyme inhibition targets, or gene expression changes have been characterized for L. nuda, and broader [immunomodulatory](/ingredients/condition/immune-support) or antidiabetic mechanisms described for related Basidiomycetes remain unconfirmed for this species.

## Clinical Summary

No clinical trials investigating Lepista nuda as a supplement or therapeutic agent have been conducted or reported in the accessible scientific literature. The entirety of mechanistic and efficacy data derives from in vitro extraction and [antioxidant](/ingredients/condition/antioxidant) assay studies, which, while methodologically rigorous in their analytical chemistry, do not establish efficacy in living systems. There are no reported outcomes in human subjects, no effect sizes applicable to clinical practice, and no standardized extract formulations that have undergone safety or pharmacokinetic evaluation. Confidence in any clinical recommendation is therefore very low, and L. nuda should currently be regarded as a nutritionally interesting wild food rather than a supplement with substantiated health claims.

## Nutritional Profile

Lepista nuda fruiting bodies provide a modest macronutrient profile typical of edible mushrooms, with significant dietary fiber, low fat, and a favorable amino acid composition dominated by leucine (9.05% of GC-MS-identified biomolecules), supporting dietary protein quality. The phenolic fraction includes p-hydroxybenzoic acid (587.90 ± 4.89 µg/g dw), catechin (400.20 µg/g dw), ellagic acid (362.60 µg/g dw), and chlorogenic acid (327.60 µg/g dw), with total phenolic content of 25.52 ± 0.56 mg GAE/g dry methanolic extract and total flavonoid content of 19.02 ± 0.80 mg catechin equivalents/g dme. Micronutrient highlights include trace ascorbic acid, β-carotene (0.39 µg/100 g in some samples), lycopene (0.20 µg/100 g), and tannins, with tocopherols and ergothioneine reported in related Basidiomycete species and potentially present. The dominant fatty acid is linolelaidic acid (21.13%), an isomer of linoleic acid; bioavailability of phenolics from cooked versus raw preparations has not been specifically studied for this species, though cooking generally reduces some thermolabile [antioxidant](/ingredients/condition/antioxidant)s.

## Dosage & Preparation

- **Wild Culinary Use (Traditional)**: Fresh fruiting bodies are cooked before consumption—boiling, sautéing, or stewing—as raw consumption may cause mild gastrointestinal upset in some individuals; no standardized serving size has been established.
- **Methanolic Extract (Research Use Only)**: Laboratory studies employed methanolic extracts at concentrations delivering EC₅₀ [antioxidant activity](/ingredients/condition/antioxidant) between 0.22 and 1.18 mg/mL depending on assay; these are analytical preparations not intended for human use.
- **Commercial Supplement Forms**: No standardized capsule, powder, or tincture formulations of L. nuda are currently commercially established with documented dosage guidance.
- **Standardization**: No pharmaceutical-grade standardization to specific phenolic markers (e.g., p-hydroxybenzoic acid or catechin content) has been established or validated for supplement manufacturing.
- **Timing and Administration**: As a food, L. nuda is consumed seasonally (autumn–winter) when fruiting; there are no clinical timing recommendations for any extract form.
- **Research Gap Note**: Effective human doses have not been determined; extrapolation from in vitro EC₅₀ data to oral dosing is not scientifically valid without absorption, distribution, [metabolism](/ingredients/condition/weight-management), and excretion (ADME) data.

## Safety & Drug Interactions

Formal toxicological evaluation of Lepista nuda is extremely limited; one mycelium study exists but provides no specific adverse event data, maximum tolerated doses, or organ-level toxicity findings, leaving the safety profile largely undefined for supplemental use. As a wild-foraged mushroom, the principal real-world risk is misidentification with toxic lookalikes such as Clitocybe nebularis or Cortinarius species, some of which contain nephrotoxic orellanine; accurate species identification by a trained mycologist is essential before consumption. Rare allergic reactions to mushroom proteins (chitinases, lectins) are possible, and raw or undercooked consumption has been anecdotally associated with gastrointestinal irritation, making thorough cooking advisable. No drug interaction data exist for L. nuda extracts; no guidance is available for pregnant or lactating individuals, and use in these populations should be avoided until safety data are established.

## Scientific Research

The available evidence base for Lepista nuda consists exclusively of preclinical in vitro studies, with no in vivo animal studies or human clinical trials identified in the published literature. A key study characterized methanolic fruiting body extracts using HPLC-MS and GC-MS, quantifying phenolic compounds and biomolecules, while validating [antioxidant activity](/ingredients/condition/antioxidant) through DPPH, β-carotene bleaching, and reducing power assays—providing chemically specific but pharmacologically limited data. Comparative analyses across geographic populations (Indian versus Portuguese samples) indicate variability in β-carotene and lycopene concentrations, suggesting that growing conditions meaningfully influence the phytochemical profile. The overall evidence quality is low by clinical standards: no randomized controlled trials, dose-response data in humans, or bioavailability studies exist, making translation of in vitro findings to human health outcomes speculative at this stage.

## Historical & Cultural Context

Lepista nuda has been foraged and consumed as a table mushroom in Europe for centuries, particularly in France, Italy, and the United Kingdom, where it is regarded as a flavorful autumnal delicacy with a violet-tinted cap and characteristic anise-like aroma. It does not feature prominently in classical herbalism or ethnopharmacological systems such as Traditional Chinese Medicine or Ayurveda, with its historical role being primarily culinary rather than medicinal. In French markets it is sold as 'pied bleu' and has been subject to limited commercial cultivation since the mid-twentieth century. Modern scientific interest in its medicinal potential is recent and largely driven by the broader trend of investigating wild edible mushrooms as sources of bioactive compounds for pharmaceutical and nutraceutical applications.

## Synergistic Combinations

No empirically validated synergistic combinations have been studied for Lepista nuda specifically; however, based on its phenolic profile, co-consumption with vitamin C-rich foods may theoretically regenerate oxidized polyphenols and extend [antioxidant activity](/ingredients/condition/antioxidant), a mechanism established for structurally similar phenolics like catechin and ellagic acid. The presence of linolelaidic acid suggests potential complementarity with other omega-6 fatty acid sources in modulating membrane oxidative dynamics, though this has not been tested for L. nuda. In the broader functional mushroom literature, beta-glucan-rich species are often combined with antioxidant-rich botanicals for [immune support](/ingredients/condition/immune-support) stacks, and if L. nuda beta-glucan content is confirmed in future research, similar synergistic pairings with Echinacea or astragalus could be hypothesized.

## Frequently Asked Questions

### What are the main antioxidant compounds in Lepista nuda?

The major antioxidant compounds identified by HPLC-MS in Lepista nuda are p-hydroxybenzoic acid (587.90 µg/g dry weight), catechin (400.20 µg/g dw), ellagic acid (362.60 µg/g dw), and chlorogenic acid (327.60 µg/g dw). These phenolics drive free radical scavenging activity, with methanolic extracts showing DPPH EC₅₀ values of 0.98–1.18 mg/mL and particularly strong lipid oxidation inhibition (β-carotene bleaching EC₅₀ 0.22–0.39 mg/mL).

### Is wood blewit safe to eat raw?

Raw or undercooked Lepista nuda is generally not recommended, as it has been anecdotally associated with gastrointestinal irritation in some individuals; thorough cooking by boiling or sautéing is the standard preparation method. There are no formal clinical toxicity studies on L. nuda, so raw consumption should be avoided as a precaution, and individuals with mushroom allergies should exercise particular care.

### Are there any clinical trials on Lepista nuda?

No clinical trials on Lepista nuda have been published; all available evidence comes from in vitro laboratory studies analyzing its chemical composition and antioxidant activity in extracted form. This means there is no human data on effective doses, safety in supplemental quantities, or confirmed health outcomes, making it premature to use L. nuda as a therapeutic supplement based on current evidence.

### How does Lepista nuda compare to other medicinal mushrooms?

Unlike well-researched medicinal mushrooms such as Ganoderma lucidum or Lentinula edodes (shiitake), Lepista nuda lacks clinical trial data, standardized extracts, or established immunomodulatory beta-glucan characterization. Its in vitro antioxidant activity is comparable to or exceeds some standards in β-carotene bleaching assays, but the evidence base is far thinner than for mainstream medicinal mushrooms, positioning it as a nutritionally promising but scientifically early-stage ingredient.

### Can Lepista nuda be confused with toxic mushrooms?

Yes, Lepista nuda can be misidentified in the wild, with the greatest danger of confusion with Clitocybe nebularis (clouded funnel), which can cause gastrointestinal toxicity, or certain Cortinarius species that contain the nephrotoxic compound orellanine. Accurate identification by an experienced mycologist is essential before foraging; key distinguishing features of L. nuda include its violet-tinged cap and gills, anise-like scent, and pink-spored print.

### What is the most bioavailable form of wood blewit supplement?

Methanolic and aqueous extracts of wood blewit demonstrate superior bioavailability compared to whole mushroom powder, as extraction methods concentrate the phenolic compounds responsible for antioxidant activity. Hot water decoction and alcohol-based tinctures are commonly used preparation methods that maximize the solubility and absorption of active constituents like p-hydroxybenzoic acid and catechin. Standardized extracts with verified phenolic content may offer more consistent bioavailability than raw or dried mushroom forms.

### Who should avoid taking wood blewit supplements?

Individuals with known mushroom allergies or mold sensitivities should exercise caution with wood blewit supplements, as cross-reactivity is possible. Those taking anticoagulant or antiplatelet medications should consult a healthcare provider before supplementation, as some mushroom species may have mild blood-thinning properties. Pregnant and nursing women should avoid supplementation without medical guidance, as safety data in these populations is limited.

### How does wood blewit's lipid peroxidation inhibition compare to its antioxidant activity?

Wood blewit demonstrates particularly potent lipid peroxidation inhibition with an EC₅₀ of 0.22–0.3 mg/mL in the β-carotene bleaching assay, which is substantially lower (more potent) than its DPPH free radical scavenging EC₅₀ of 0.98–1.18 mg/mL. This suggests that wood blewit's phenolic compounds are especially effective at protecting lipids and fatty acids from oxidative damage, a property relevant for cellular membrane protection and metabolic health. The difference between these two assays indicates wood blewit may be particularly valuable for preventing lipid-based oxidative damage in tissues with high fat content.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*